checkAd
    Vaxxinity Registered (A) Aktie
    0,1111
     
    USD
    -15,26 %
    -0,0200 USD
    Letzter Kurs 09.05.24 Nasdaq
    0,1113
     
    USD
    11.200 STK
    Geldkurs 08.05.24
    0,1138
     
    USD
    8.400 STK
    Briefkurs 08.05.24
    ISIN: US92244V1044 · WKN: A3C7GC · SYM: VAXX · USA

    Neueste Nachrichten

    Vaxxinity Issues Shareholder Letter
    20.04.24 · globenewswire · Vaxxinity Registered (A)
    Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
    19.04.24 · globenewswire · Vaxxinity Registered (A)
    Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
    28.03.24 · globenewswire · Vaxxinity Registered (A)
    Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates
    27.03.24 · globenewswire · Vaxxinity Registered (A)
    Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD 2024
    07.03.24 · globenewswire · Vaxxinity Registered (A)
    Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published
    15.02.24 · globenewswire · Vaxxinity Registered (A)
    Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024
    13.02.24 · globenewswire · Vaxxinity Registered (A)
    Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
    30.01.24 · globenewswire · Vaxxinity Registered (A)
    Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida
    18.01.24 · globenewswire · Vaxxinity Registered (A)
    Vaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference
    03.01.24 · globenewswire · Vaxxinity Registered (A)
    Vaxxinity to Present at Upcoming November Medical and Investor Conferences
    14.11.23 · globenewswire · Vaxxinity Registered (A)
    Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update
    08.11.23 · globenewswire · Vaxxinity Registered (A)